• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.

作者信息

Gomes M Gabriela M, Gordon Stephen B, Lalloo David G

机构信息

Liverpool School of Tropical Medicine, United Kingdom; CIBIO-InBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Portugal; Instituto de Matemática e Estatística, Universidade de São Paulo, Brazil.

Liverpool School of Tropical Medicine, United Kingdom; Malawi Liverpool Wellcome Trust Programme of Clinical Tropical Research, Blantyre, Malawi.

出版信息

Vaccine. 2016 Jun 8;34(27):3007-3009. doi: 10.1016/j.vaccine.2016.04.065. Epub 2016 May 10.

DOI:10.1016/j.vaccine.2016.04.065
PMID:27177948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5087849/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b2/5418366/fa1c4606aeea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b2/5418366/fa1c4606aeea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b2/5418366/fa1c4606aeea/gr1.jpg

相似文献

1
Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence.临床试验：随着疾病发病率上升疫苗效力下降的数学原理。
Vaccine. 2016 Jun 8;34(27):3007-3009. doi: 10.1016/j.vaccine.2016.04.065. Epub 2016 May 10.
2
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity.在疫苗相关异质性情况下，根据急性传染原的流行情况估算疫苗效力。
Math Biosci. 1993 Sep-Oct;117(1-2):271-81. doi: 10.1016/0025-5564(93)90028-9.
3
Use of sample size for estimating efficacy of a vaccine against an infectious disease.
Am J Vet Res. 2001 Oct;62(10):1582-4. doi: 10.2460/ajvr.2001.62.1582.
4
Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.疫苗接种、进化与疫苗效力的变化：一个理论框架
Proc Biol Sci. 1995 Sep 22;261(1362):389-93. doi: 10.1098/rspb.1995.0164.
5
Epidemic enhancement in partially immune populations.部分免疫人群中的疫情增强。
PLoS One. 2007 Jan 17;2(1):e165. doi: 10.1371/journal.pone.0000165.
6
Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy.疫苗可预防疾病发病率作为制定疫苗政策时疫苗效力的补充。
Vaccine. 2014 May 30;32(26):3133-8. doi: 10.1016/j.vaccine.2014.04.019. Epub 2014 Apr 13.
7
Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan.日本预防传染病疫苗临床试验指南修订提案
Vaccine. 2022 Oct 12;40(43):6295-6304. doi: 10.1016/j.vaccine.2022.09.036. Epub 2022 Sep 24.
8
Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.从人体免疫原性研究推断甲型H5N1流感病毒灭活疫苗的理论效力。
Vaccine. 2016 Jul 19;34(33):3796-802. doi: 10.1016/j.vaccine.2016.05.067. Epub 2016 Jun 20.
9
Field evaluation of vaccine efficacy.疫苗效力的现场评估。
Bull World Health Organ. 1985;63(6):1055-68.
10
New approaches to the assessment of vaccine herd protection in clinical trials.疫苗临床试验中群体保护评估的新方法。
Lancet Infect Dis. 2011 Jun;11(6):482-7. doi: 10.1016/S1473-3099(10)70318-2.

引用本文的文献

1
Non-selective distribution of infectious disease prevention may outperform risk-based targeting.非选择性传染病预防的分配可能优于基于风险的目标定位。
Nat Commun. 2022 May 31;13(1):3028. doi: 10.1038/s41467-022-30639-3.
2
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.个体对 SARS-CoV-2 的易感性或暴露程度的差异降低了群体免疫阈值。
J Theor Biol. 2022 May 7;540:111063. doi: 10.1016/j.jtbi.2022.111063. Epub 2022 Feb 18.
3
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study.

本文引用的文献

1
Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure.基于许可后横断面流行率数据拟合的动态模型来扩大疫苗效力估计。
Epidemics. 2016 Mar;14:71-82. doi: 10.1016/j.epidem.2015.11.001. Epub 2015 Dec 9.
2
Design, recruitment, and microbiological considerations in human challenge studies.人体挑战研究的设计、招募和微生物学考虑因素。
Lancet Infect Dis. 2015 Jul;15(7):840-51. doi: 10.1016/S1473-3099(15)00068-7. Epub 2015 May 27.
3
A missing dimension in measures of vaccination impacts.
加州州立监狱中囚犯的 2019 年冠状病毒病（COVID-19）疫苗有效性：回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e838-e845. doi: 10.1093/cid/ciab1032.
4
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
5
Pathogen transmission from vaccinated hosts can cause dose-dependent reduction in virulence.疫苗接种宿主传播病原体可导致毒力呈剂量依赖性降低。
PLoS Biol. 2020 Mar 5;18(3):e3000619. doi: 10.1371/journal.pbio.3000619. eCollection 2020 Mar.
6
Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications.两出生队列研究中轮状病毒感染和胃肠炎的异质性易感性：参数估计和流行病学意义。
PLoS Comput Biol. 2019 Jul 26;15(7):e1007014. doi: 10.1371/journal.pcbi.1007014. eCollection 2019 Jul.
7
An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections.基于代理的登革热病毒传播模型展示了对突破性感染的不确定性如何影响疫苗接种效果预测。
PLoS Comput Biol. 2019 Mar 20;15(3):e1006710. doi: 10.1371/journal.pcbi.1006710. eCollection 2019 Mar.
8
Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose.有限的可用证据支持了在更高暴露剂量下疫苗效力降低的理论预测。
Sci Rep. 2019 Mar 1;9(1):3203. doi: 10.1038/s41598-019-39698-x.
9
Immune History and Influenza Vaccine Effectiveness.免疫史与流感疫苗效力
Vaccines (Basel). 2018 May 21;6(2):28. doi: 10.3390/vaccines6020028.
10
Variation in Wolbachia effects on Aedes mosquitoes as a determinant of invasiveness and vectorial capacity.沃尔巴克氏体对伊蚊的影响的变化是决定其入侵性和媒介能力的因素。
Nat Commun. 2018 Apr 16;9(1):1483. doi: 10.1038/s41467-018-03981-8.
疫苗接种影响衡量指标中缺失的一个维度。
PLoS Pathog. 2014 Mar 6;10(3):e1003849. doi: 10.1371/journal.ppat.1003849. eCollection 2014 Mar.
4
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.BCG 疫苗预防结核病的效果：随机对照试验的系统评价。
Clin Infect Dis. 2014 Feb;58(4):470-80. doi: 10.1093/cid/cit790. Epub 2013 Dec 13.
5
Estimating the per-exposure effect of infectious disease interventions.估算传染病干预措施的每暴露效应。
Epidemiology. 2014 Jan;25(1):134-8. doi: 10.1097/EDE.0000000000000003.
6
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.RTS,S/AS01 疟疾疫苗在非洲婴儿中的 3 期临床试验。
N Engl J Med. 2012 Dec 13;367(24):2284-95. doi: 10.1056/NEJMoa1208394. Epub 2012 Nov 9.
7
How host heterogeneity governs tuberculosis reinfection?宿主异质性如何影响结核病再感染？
Proc Biol Sci. 2012 Jun 22;279(1737):2473-8. doi: 10.1098/rspb.2011.2712. Epub 2012 Feb 22.
8
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.随机试验中明显下降的疗效：泰国RV144艾滋病疫苗和南非CAPRISA 004杀微生物剂试验的实例。
AIDS. 2012 Jan 14;26(2):123-6. doi: 10.1097/QAD.0b013e32834e1ce7.
9
A Bayesian framework for parameter estimation in dynamical models.贝叶斯框架在动态模型参数估计中的应用。
PLoS One. 2011;6(5):e19616. doi: 10.1371/journal.pone.0019616. Epub 2011 May 24.
10
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.亚洲发展中国家婴幼儿五价轮状病毒疫苗对严重轮状病毒胃肠炎的效力：一项随机、双盲、安慰剂对照试验。
Lancet. 2010 Aug 21;376(9741):615-23. doi: 10.1016/S0140-6736(10)60755-6. Epub 2010 Aug 6.